Abstract
LX15 is more potent than AG014699 in PARP-1 inhibitory activity and BRCA-1 deficient cell inhibitory activity. It is more effective than AG014699 in potentiating the antitumor activity of TMZin vitro and in vivo.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have